Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
NCT01359969
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Hereditary Angioedema
Interventions
DRUG:
rhC1INH
Sponsor
Pharming Technologies B.V.